tiprankstipranks

Rebecca Byam Insider Profile

11 Followers
Rebecca Byam, CFO at HCW Biologics, holds 1.38M shares in HCW Biologics (Ticker: HCWB).
tipranks
Rebecca Byam

Rebecca Byam
HCW Biologics (HCWB)
CFO

Ranked #94,972 out of 98,909 Corporate Insiders

Profitable Transactions

0%
0 out of 20 Profitable Transactions

Average Return

-33.10%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
100.00%
A breakdown of Rebecca Byam's holdings

Insider Roles

HCW Biologics
(HCWB)
CFO
Roles that Rebecca Byam holds in companies

Most Profitable Insider Trade

Stock:
HCW Biologics
(HCWB)
Rating:Informative Buy
Date:Jun 15, 2022 - Jun 15, 2023
Return:-10.80%
The most profitable trade made by Rebecca Byam

Rebecca Byam's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
HCW Biologics
Feb 22, 2024
CFO
Uninformative Buy
1.06M
$1.52M
Success Rate for
HCWB
0 out of 20 profitable transactions on
HCWB
0%
Average Return for
HCWB
Average return per transaction on
HCWB
-33.17%
Date
Transaction
Amount
No. of Shares
Price per Share
Profit
Link to Report
Jul 23, 2021
Informative Buy
$200.00K
-
$8.00
-54.10%
Nov 26, 2021
Informative Buy
$3.78K
-
$0.14
-16.40%
Jun 15, 2022
Informative Buy
$160.59K
-
$2.41
-10.80%
Aug 26, 2022
Informative Buy
$229.38K
-
$2.54
-25.30%
Aug 30, 2022
Informative Buy
$50.90K
-
$2.54
-25.70%
List of latest transactions for each holding click on a transaction to see Rebecca Byam's performance on stock

Rebecca Byam insider profile FAQ

What is the percentage of profitable transactions made by Rebecca Byam?
The percentage of profitable transactions made by Rebecca Byam is 0%.
    What is the average return per transaction made by Rebecca Byam?
    The average return per transaction made by Rebecca Byam is -33.10%.
      What stocks does Rebecca Byam hold?
      Rebecca Byam holds: HCWB stocks.
        What was Rebecca Byam’s latest transaction?
        Rebecca Byam latest transaction was an Uninformative Buy of $1.06M.
          What was Rebecca Byam's most profitable transaction?
          Rebecca Byam’s most profitable transaction was an Informative Buy of HCWB stock on June 15, 2022. The return on the trade was -10.80%.
            What is Rebecca Byam's role in HCW Biologics?
            Rebecca Byam's role in HCW Biologics is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.